Following on the heels of its recent placement of Joe Papa as chief executive of Valeant Pharmaceuticals and Frederic Eshelman and Thomas W. Ross Sr. as company directors, Odgers Berndtson has now placed three additional board nominees into contention at the Canadian-based global pharma giant. Dr. Argeris N. Karabelas, Russel C. Robertson and Amy B. Wechsler M.D., have

Odgers Berndtson has recruited Joseph C. Papa as chairman and chief executive officer of Valeant Pharmaceuticals International. The placement of Mr. Papa comes just weeks after Valeant revealed that its embattled CEO, J. Michael Pearson, was leaving after eight years with the company. The search was led by Odgers U.S. vice chairman and director John Hawkins, who

Odgers Berndtson has opened a Houston office with the addition of three new partners who will service the leadership needs of clients in the energy and industrial space. Jim Thompson, Gary Payne, and Mary Campagnano, all formerly managing partners at Allen Austin, have joined the firm in its new location. Mr. Thompson will serve U.S. industrial

Odgers Berndtson has expanded its public sector search expertise in Canada with the addition of Jane Griffith as a new partner in its academic practice as well as John King and Gino Picciano in the firm’s healthcare practice. With a focus on the recruitment of senior leaders in the academic sector, Ms. Griffith has worked with universities,